CASP8 rs2240751: Understanding This Ancestral Genetic Variant
The rs2240751 variant is a single nucleotide polymorphism located within the CASP8 gene, which plays a critical role in the body's programmed cell death process. Research into this variant focuses on its potential influence on cancer susceptibility and its varied distribution across different ancestral populations.
What each genotype means
Common ancestral genotype
This is the most common genotype observed in many global populations. Research into this variant often uses this genotype as the baseline for comparing cancer susceptibility, though associations remain limited and require further study.
This is the most frequent genotype in many populations, though its prevalence varies significantly by ancestry.
Heterozygous genotype
Individuals with this genotype carry one copy of each allele. Some studies have investigated this variant in the context of cancer susceptibility, but evidence remains limited and results are not definitive for any individual.
This genotype is commonly observed, with the minor allele frequency ranging from approximately 0.15 in African ancestries to 0.45 in European ancestries.
Homozygous variant genotype
This genotype represents the presence of two copies of the minor allele. While some research has explored potential associations with cancer susceptibility, the evidence is limited and inconsistent across different studies.
This genotype is less common than the heterozygous form, with frequency patterns reflecting the underlying minor allele distribution across different continental populations.
What is rs2240751?
The rs2240751 variant is a specific genetic marker, or single nucleotide polymorphism (SNP), situated within the CASP8 gene. In genomics, a SNP represents a variation at a single position in the DNA sequence among individuals. This particular variant is categorized as an ancestral marker, meaning it has been present in human populations for a significant period. Because it is located within a gene involved in complex biological pathways, researchers study it to determine if it influences how cells function or respond to stress. It is important to note that the presence of this variant does not inherently indicate a health condition; rather, it is a point of interest for scientists investigating how subtle genetic differences might contribute to biological diversity and disease risk across different groups of people.
The Role of the CASP8 Gene
The CASP8 gene provides instructions for producing the caspase-8 protein. This protein is a key initiator in the extrinsic apoptotic pathway, which is the body's mechanism for programmed cell death. Apoptosis is a vital process that allows the body to eliminate damaged, unnecessary, or potentially harmful cells, such as those that might become cancerous. When this pathway is functioning correctly, it helps maintain tissue homeostasis. Because caspase-8 is so central to this "self-destruct" signal, researchers have long hypothesized that variations in the CASP8 gene could alter the efficiency of this process. If the apoptotic response is either too active or suppressed, it may theoretically influence how cells survive or proliferate, which is why CASP8 variants are frequently examined in the context of oncology and cellular biology research.
Research and Evidence Strength
The evidence linking rs2240751 to specific health outcomes is currently considered limited. While the broader CASP8 gene has been extensively studied in relation to various cancers—such as breast and colorectal cancer—the specific functional impact of the rs2240751 variant remains a subject of ongoing investigation. Many studies in the GWAS Catalog and other databases look for statistical associations between genetic variants and disease traits. However, finding a statistical correlation does not always prove a direct cause-and-effect relationship. Because cancer is a multifactorial disease influenced by a combination of genetics, environment, and lifestyle, the effect size of any single SNP like rs2240751 is typically very small. Consequently, current scientific consensus suggests that this variant should be viewed as a piece of a much larger, complex puzzle rather than a definitive predictor of health.
Population Frequency
Genetic variants often show distinct patterns of frequency depending on a person's ancestral background. For rs2240751, the minor allele frequency is notably different across global populations. Data indicates that the frequency ranges from approximately 0.15 in African ancestries to as high as 0.45 in European ancestries. These differences are common in human genetics and reflect the historical migration and evolutionary pressures experienced by different groups. Understanding these frequency variations is essential for researchers, as it helps ensure that genetic studies are representative of diverse populations. It also highlights why findings from one ancestral group cannot always be generalized to others, emphasizing the need for inclusive and large-scale genomic research to fully understand the global landscape of human genetic variation.
Interpreting Your Genetic Information
If you have received information about your rs2240751 genotype, it is important to understand that this data is for educational purposes only. You cannot use this information to diagnose yourself with a disease or to predict your future health with certainty. Genetic associations are statistical observations made across large groups of people and do not necessarily apply to the health trajectory of any single individual. If you are concerned about your risk for cancer or other conditions, the most effective approach is to consult with a healthcare professional or a certified genetic counselor. They can evaluate your personal and family medical history alongside your genetic information to provide context. Never make changes to your medical care or lifestyle based solely on a single genetic variant without first discussing it with your clinician.
How common is this variant?
The minor allele frequency for rs2240751 ranges from approximately 0.15 in African ancestries to approximately 0.45 in European ancestries.
Frequently asked questions
Is rs2240751 a marker for cancer risk?
While the CASP8 gene is involved in pathways related to cancer, the evidence linking the specific rs2240751 variant to cancer risk is limited. Statistical associations found in research studies do not imply that this variant is a direct cause of disease.
Can I use this SNP to predict my health?
No, you cannot use this SNP to predict your health. Genetic variants like rs2240751 have very small effects and are only one of many factors, including environment and lifestyle, that influence health outcomes.
Why does the frequency of this variant differ by ancestry?
Differences in allele frequencies across populations are common and result from human evolutionary history, including migration and genetic drift. These patterns are a normal part of human genetic diversity.
Should I be worried if I have the GG genotype?
No, there is no reason to be worried. Having a specific genotype for this variant is a normal variation and does not constitute a medical diagnosis or a high-risk health indicator.
Sources & further reading
Educational information only, last refreshed 10/14/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2240751?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29